Prevent AMD Vision Loss with Remote Monitoring

Proven 10-year ALOFT Study Results

Sid Schechet, MD; and Sean W. Smolenyak, OD

Show Description +

Sidney A. Schechet, MD, and Sean W. Smolenyak, OD, discuss the results of the ALOFT study, showing levels of patient compliance with at-home age-related macular degeneration (AMD) monitoring. Dr. Schechet shares how his use of cutting-edge technology such as ForeseeHome (Notal Vision) has led to increased referrals to his practice.

Posted: 8/09/2022

Keywords:

Videos from Notal Vision

•

AMD Patient Co-Management

•

Notal Vision

Up Next

Name: Proven 10-year ALOFT Study Results
Uploaded: 2022-08-09T17:15:36+00:00
Description: Sidney A. Schechet, MD, and Sean W. Smolenyak, OD, discuss the results of the ALOFT study, showing levels of patient compliance with at-home age-related macular degeneration (AMD) monitoring. Dr. Schechet shares how his use of cutting-edge technology such as ForeseeHome (Notal Vision) has led to increased referrals to his practice.

Wet AMD fellow eye standard of care is not enough: understanding the barriers

Allen Ho, MD; Miguel Busquets, MD; Byron Ladd, MD

Notal Vision Monitoring Center

Your Practice’s Partner in AMD Patient Care

Protecting Wet AMD Patients' Fellow Eyes

Wet AMD fellow eye standard of care is not enough: understanding the barriers

Allen Ho, MD; Miguel Busquets, MD; Byron Ladd, MD

The impact of functional vision in the fellow eye for the AMD patient

Allen Ho, MD; Miguel Busquets, MD; Byron Ladd, MD

A safety net for wet AMD patients’ fellow eyes

Allen Ho, MD; Miguel Busquets, MD; Byron Ladd, MD

AMD Patient Co-Management

Extending Care to Patients' Homes

Sid Schechet, MD; and Sean W. Smolenyak, OD

Easy Referral to a Digital Health Provider

Sid Schechet, MD; and Sean W. Smolenyak, OD

Quality Patient Services by a Monitoring Center

Sid Schechet, MD; and Sean W. Smolenyak, OD

Proven 10-year ALOFT Study Results

Sid Schechet, MD; and Sean W. Smolenyak, OD

Proven Improved Long-term Visual Outcomes

Analysis of the Long-term Visual Outcomes of ForeseeHome Remote Telemonitoring: The ALOFT Study

Michael J. Elman, MD

Back to All Videos

Proven 10-year ALOFT Study Results

Sid Schechet, MD; and Sean W. Smolenyak, OD

Sidney A. Schechet, MD, and Sean W. Smolenyak, OD, discuss the results of the ALOFT study, showing levels of patient compliance with at-home age-related macular degeneration (AMD) monitoring. Dr. Schechet shares how his use of cutting-edge technology such as ForeseeHome (Notal Vision) has led to increased referrals to his practice.

Posted: 8/09/2022

Keywords:

Videos from Notal Vision

•

AMD Patient Co-Management

•

Notal Vision

Resources

ALOFT Study article

View Resource

Improving the Standard of Care in AMD

Read Insert

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration

Journal of Clinical Medicine

View Resource

AMD Home Monitoring

View Resource

About Notal Vision

Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated devices, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision.

The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic monitoring center and the epicenter of patient engagement. Led by practicing ophthalmologists and staffed by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. ForeseeHome helps physicians detect conversion to wet AMD earlier and Home OCT pipeline technology will extend monitoring services for exudative retinal diseases.

Visit us online: notalvision.com

Follow Notal Vision